Skip to main content
Clinical Trials/NCT03234816
NCT03234816
Completed
Phase 4

Vasopressor Prophylaxis After Spinal Anesthesia: A Dose Finding Study

Cairo University1 site in 1 country270 target enrollmentAugust 2, 2017

Overview

Phase
Phase 4
Intervention
Bupivacaine
Conditions
Cesarean Section Complications
Sponsor
Cairo University
Enrollment
270
Locations
1
Primary Endpoint
incidence of postspinal hypotension
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Norepinephrine has been recently introduced as a prophylactic vasopressor during Cesarean delivery with promising results ; However, the optimum dose for efficient prophylaxis with the least side effects is not known. In this study, we will compare three doses (0.05, 0.1, 0.15 mcg/Kg/min) of norepinephrine for prophylaxis against Post-Spinal hypotension during cesarean delivery.

Detailed Description

Maternal hypotension is a common complication after spinal anesthesia for cesarean delivery (CD). Using vasopressors have been considered a gold standard for prevention of post-spinal hypotension (PSH) during CD. Norepinephrine (NE) is a potent vasopressor characterized by both α adrenergic agonistic activity in addition to a weak β adrenergic agonistic activity; thus, NE is considered a vasopressor with minimal cardiac depressant effect; these pharmacological properties would make NE an attractive alternative to phenylephrine and ephedrine (the most commonly used vasopressors in obstetric anesthesia). Norepinephrine has been recently introduced as a prophylactic vasopressor during CD with promising results; However, the optimum dose for efficient prophylaxis with the least side effects is not known. In this study, we will compare three doses (0.05, 0.1, 0.15 mcg/Kg/min) of norepinephrine for prophylaxis against PSH during CD.

Registry
clinicaltrials.gov
Start Date
August 2, 2017
End Date
December 10, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ahmed Hasanin

Principal investigator, Lecturer of anesthesia and critical care medicine

Cairo University

Eligibility Criteria

Inclusion Criteria

  • full term singleton pregnant women
  • Scheduled for elective Cesarean Delivery
  • Aged between 18 and 40 years

Exclusion Criteria

  • Cardiac morbidities
  • Hypertensive disorders of pregnancy,
  • Peripartum bleeding
  • Baseline systolic blood pressure (SBP) \< 100 mmHg
  • Body mass index \> 35

Arms & Interventions

- 0.05 mcg /Kg/min group

will receive norepinephrine 0.05 mcg /Kg/min after spinal anesthesia by bupivacaine till five-minutes after delivery of the fetus

Intervention: Bupivacaine

- 0.05 mcg /Kg/min group

will receive norepinephrine 0.05 mcg /Kg/min after spinal anesthesia by bupivacaine till five-minutes after delivery of the fetus

Intervention: Norepinephrine 0.05 mcg /Kg/min

- 0.1 mcg /Kg/min group

will receive norepinephrine 0.1 mcg /Kg/min after spinal anesthesia by bupivacaine till five-minutes after delivery of the fetus

Intervention: Norepinephrine 0.1 mcg /Kg/min

- 0.1 mcg /Kg/min group

will receive norepinephrine 0.1 mcg /Kg/min after spinal anesthesia by bupivacaine till five-minutes after delivery of the fetus

Intervention: Bupivacaine

- 0.15 mcg /Kg/min group

will receive norepinephrine 0.15 mcg /Kg/min after spinal anesthesia by bupivacaine till five-minutes after delivery of the fetus

Intervention: Norepinephrine 0.15 mcg /Kg/min

- 0.15 mcg /Kg/min group

will receive norepinephrine 0.15 mcg /Kg/min after spinal anesthesia by bupivacaine till five-minutes after delivery of the fetus

Intervention: Bupivacaine

Outcomes

Primary Outcomes

incidence of postspinal hypotension

Time Frame: 30 minutes after spinal anesthesia

The number of patients who develop hypotension (defined as decreased SBP less than 80% of the baseline reading during the period from intrathecal injection till delivery of the fetus) after spinal block divided by the total number in the group

Secondary Outcomes

  • heart rate(90 minutes after spinal anesthesia)
  • vomiting(120 minutes after spinal anesthesia)
  • nausea(120 minutes after spinal anesthesia)
  • ephedrine consumption(60 minutes after spinal anesthesia)
  • Atropine consumption(60 minutes after spinal anesthesia)
  • APGAR score(10 minutes after delivery)
  • incidence of severe postspinal hypotension(30 minutes after spinal anesthesia)
  • arterial blood pressure(90 minutes after spinal anesthesia)

Study Sites (1)

Loading locations...

Similar Trials